These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 23465968)
1. Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach. McDermott S; O'Neill AC; Skehan SJ Clin Imaging; 2013; 37(2):194-200. PubMed ID: 23465968 [TBL] [Abstract][Full Text] [Related]
2. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Niederle MB; Hackl M; Kaserer K; Niederle B Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725 [TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): a closer look at the characteristics of these diverse tumors. Pape UF Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):8-11. PubMed ID: 25768103 [No Abstract] [Full Text] [Related]
4. Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases. Stoica-Mustafa E; Pechianu C; Iorgescu A; Hortopan M; Dima SO; Tomulescu V; Dumitraşcu T; Ungureanu C; Andronesi D; Popescu I; Herlea V Rom J Morphol Embryol; 2012; 53(2):351-5. PubMed ID: 22732805 [TBL] [Abstract][Full Text] [Related]
5. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Rindi G; Capella C; Solcia E Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598 [TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine tumors in children and young adults. Khanna G; O'Dorisio SM; Menda Y; Kirby P; Kao S; Sato Y Pediatr Radiol; 2008 Mar; 38(3):251-9, quiz 358-9. PubMed ID: 17906857 [TBL] [Abstract][Full Text] [Related]
8. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Klöppel G Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Oberg K Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940 [TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Anlauf M Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474 [TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic disease in patients with neuroendocrine tumors. Niederhuber JE; Fojo T Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495 [TBL] [Abstract][Full Text] [Related]
13. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria. Martin JA; Warner RR; Wisnivesky JP; Kim MK Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622 [TBL] [Abstract][Full Text] [Related]
14. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature. Goldin SB; Aston J; Wahi MM Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253 [TBL] [Abstract][Full Text] [Related]
15. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ; Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454 [No Abstract] [Full Text] [Related]
16. [Morphological imaging of gastroenteropancreatic neuroendocrine tumours]. Camera L; Bresciani M; Soscia E; Percopo V; Mainenti PP; Salvatore M Minerva Endocrinol; 2001 Sep; 26(3):123-8. PubMed ID: 11753234 [TBL] [Abstract][Full Text] [Related]
17. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Strosberg J; Nasir A; Coppola D; Wick M; Kvols L Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957 [TBL] [Abstract][Full Text] [Related]
18. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators. Ardill JE; O'Dorisio TM Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544 [TBL] [Abstract][Full Text] [Related]
19. [The new classification of neuroendocrine tumors from the clinical viewpoint]. Schürmann G; Senninger H Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831 [No Abstract] [Full Text] [Related]
20. Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS). Boudreaux JP Endocrinol Metab Clin North Am; 2011 Mar; 40(1):163-71, ix. PubMed ID: 21349417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]